Abstract: Observational Studies Evaluating Biosimilar Agents: A Focused Literature Review

 

Abstract: Observational Studies Evaluating Biosimilar Agents: A Focused Literature Review

Cost-containment in health care paired with global regulatory approvals of biosimilar agents pave the way for less expensive alternatives to complex biologics. Regulators and payers increasingly demand robust safety and effectiveness data in real-world settings. Our objective was to identify and describe characteristics of observational studies involving biosimilars.